FUBP1 (Center), 240-268 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-FUBP1 (Center), 240-268 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | FUBP1 (Center), 240-268 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse, rat |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.45 |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This FUBP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 240-268 amino acids from the Central region of human FUBP1. This gene encodes a ssDNA binding protein that activatesthe far upstream element (FUSE) of c-myc and stimulates expressionof c-myc in undifferentiated cells. Regulation of FUSE by FUBPoccurs through single-strand binding of FUBP to the non-codingstrand. This protein has been shown to function as an ATP-dependentDNA helicase. |
| Immunogen | n/a |
| Other Names | [Far upstream element-binding protein 1; FBP; FUSE-binding protein 1; DNA helicase V; hDH V; FUBP1] |
| Gene, Accession # | [FUBP1], Gene ID: 8880, NCBI: NP_003893.2, UniProt: Q96AE4 |
| Catalog # | MBS9212810 |
| Price | $165, $370 |
| Order / More Info | FUBP1 (Center), 240-268 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Hsiao, H.H., et al. Biochemistry 49(22):4620-4634(2010) Rabenhorst, U., et al. Hepatology 50(4):1121-1129(2009) Malz, M., et al. Hepatology 50(4):1130-1139(2009) Martins-de-Souza, D., et al. Eur Arch Psychiatry Clin Neurosci 259(3):151-163(2009) Jang, M., et al. Oncogene 28(12):1529-1536(2009) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies